Johnson & Johnson COVID Vaccine Recipients Almost 4X as Likely to Get Blood Clots: Study

Johnson & Johnson COVID Vaccine Recipients Almost 4X as Likely to Get Blood Clots: Study: The study also noted that women aged 30-49 showed the highest risk levels among all recipients counted.

Comments

Popular posts from this blog

Reduced public health measures contributed to deadly COVID-19 surge in the Americas, PAHO Director says - PAHO/WHO | Pan American Health Organization